Supplier Quality Agreement Template for International Trade: Key Clauses and Negotiation Guide

A Supplier Quality Agreement (SQA) is a legally binding document between a buyer and a supplier that defines the quality standards, testing requirements, compliance obligations, and remedies for quality failures applicable to products traded between the parties. For Taiwan brands sourcing components, raw materials, or finished products for export to the US, Australia, and Japan, an SQA is the single most important quality management tool because it establishes clear, measurable expectations before production begins and provides contractual remedies when those expectations are not met.

Without a formal SQA, quality disputes become difficult to resolve because there is no agreed standard against which to measure performance. Common disputes in international trade include: the supplier delivering products that meet the supplier's internal specifications but not the buyer's market-specific requirements (for example, a food ingredient that complies with Taiwan food safety standards but not Japan's Food Sanitation Act limits), the supplier making formula or material substitutions without notifying the buyer, and disagreements about who bears the cost of defective products that have already been shipped and are sitting in a foreign warehouse. An SQA prevents these disputes by documenting expectations in advance.

The SQA is particularly critical for Taiwan brands because regulatory compliance requirements differ significantly across the US, Australia, and Japan markets. A raw material supplier in Taiwan may not be aware that Australia's TGA prohibits certain ingredients in therapeutic goods, or that Japan's Food Sanitation Act has different microbiological limits than Taiwan's food safety standards. The SQA must specify which market-specific standards apply to the supplied products and require the supplier to certify compliance with those standards. This contractual obligation shifts the compliance verification burden to the supply chain, where it can be addressed most efficiently.

The investment in developing a comprehensive SQA is modest: USD 2,000 to USD 5,000 for legal drafting with an international trade attorney, plus the management time to define specifications and negotiate terms with each supplier. The return on this investment is measured in avoided quality failures: a single batch of non-compliant raw material that results in a product recall in Japan can cost JPY 10 million to JPY 50 million, while a rejected container at Australian quarantine costs AUD 5,000 to AUD 20,000. An SQA that prevents even one such incident per year pays for itself many times over.

The Specifications clause is the foundation of the SQA. Attach a detailed Product Specification Document (PSD) as an appendix to the agreement, covering: physical specifications (appearance, color, odor, particle size, moisture content), chemical specifications (active ingredient identity and assay, heavy metals limits, pesticide residue limits, solvent residue limits), microbiological specifications (total plate count, yeast and mold, E. coli, Salmonella, Staphylococcus aureus), and performance specifications (dissolution rate, disintegration time, stability under specified conditions). Each specification must include a test method reference (USP, JP, EP, or AOAC method number) and acceptable limits. Avoid vague terms like "meets industry standards" -- specify exactly which standard and which limits.

The Testing and Certification clause defines who performs quality testing, when testing occurs, and what documentation is required. Specify three testing stages: incoming raw material testing (supplier tests incoming raw materials against PSD specifications before production), in-process testing (supplier performs specified tests during production at defined checkpoints), and finished product testing (supplier performs full specification testing on each batch of finished product). For each stage, define the sampling plan (for example, AQL 1.0 for critical defects, AQL 2.5 for major defects per ISO 2859-1), the test methods, and the required documentation (Certificate of Analysis with actual test results, not just pass/fail statements).

The Change Control clause prevents suppliers from making unauthorized changes to materials, formulas, processes, or manufacturing sites. Require the supplier to provide written notification at least 90 days before implementing any change to: raw material suppliers or grades, formulation or recipe, manufacturing process steps, manufacturing equipment, manufacturing site, and testing methods. Specify that changes affecting product quality, safety, or regulatory compliance require your written approval before implementation. This clause is critical because supplier-initiated changes (such as switching to a cheaper raw material supplier) are a leading cause of quality failures in international supply chains.

The Traceability clause requires the supplier to maintain batch-level traceability from raw material receipt through finished product shipment. Each batch of supplied product must be traceable to: the specific raw material lots used, the manufacturing date and time, the production equipment used, the identity of production operators, and all quality test results. Traceability records must be retained for a minimum period (7 years for food and supplements, 10 years for medical devices and pharmaceuticals) and produced within 48 hours of your request. This clause is essential for product recall preparedness, as regulations in the US, Australia, and Japan all require rapid traceability in the event of a safety issue.

The Regulatory Compliance clause specifies which market-specific regulations the supplied products must comply with. List each applicable regulation by name and jurisdiction: "All supplied products must comply with US FDA 21 CFR Part 111 (cGMP for dietary supplements), Australia TGA Therapeutic Goods Act 1989 and Permissible Ingredients Determination, and Japan Food Sanitation Act and relevant MHLW notices." Require the supplier to monitor changes in these regulations and notify you within 30 days of any regulatory change that affects the supplied products. Include a warranty that the supplier has the technical capability to assess compliance with these regulations, and a representation that the supplier will not knowingly supply products that violate any listed regulation.

The Audit Rights clause grants you the right to audit the supplier's manufacturing facility, quality management system, and records at reasonable notice (typically 30 days for scheduled audits, 48 hours for cause-based audits triggered by quality failures). Specify the scope of audit rights: facility inspection, production observation, quality record review, raw material storage inspection, and employee interview. Include the right to engage third-party auditors on your behalf and to share audit findings with your regulatory authorities (TGA, FDA, MHLW) if required. Audit frequency should be at least annually for critical suppliers (those providing key active ingredients or finished products for sale) and biennially for non-critical suppliers.

The Defect Resolution clause defines the process and remedies when supplied products fail to meet specifications. Specify the notification process (you notify the supplier in writing within 14 days of discovering a defect, providing test results and affected batch numbers), the investigation timeline (supplier must provide root cause analysis within 30 days), and the remedies available: replacement of defective products at supplier's cost, refund of purchase price for defective products, reimbursement of testing costs incurred to identify the defect, and reimbursement of consequential costs (such as product recall expenses, customs penalties, and customer claims) if the defect was caused by supplier's failure to comply with the SQA.

The Limitation of Liability clause should be negotiated carefully. Suppliers typically seek to cap their total liability at the value of the defective order, while buyers (especially those selling in litigious markets like the US) need the supplier to bear liability for consequential damages including product recall costs, regulatory penalties, and product liability settlements. A reasonable compromise is to cap the supplier's liability at the greater of: the value of the defective shipment, or the supplier's product liability insurance coverage amount. This approach aligns the supplier's maximum exposure with their insurance protection and incentivizes them to maintain adequate insurance coverage.

Start negotiations by sharing a draft SQA with the supplier, rather than asking the supplier to propose terms. The party who drafts the initial agreement sets the baseline for negotiations and typically retains more favorable terms even after concessions. Your draft should be professionally formatted, include all clauses described above, and reference the specific Product Specification Document that applies to the supplied products. Present the SQA as a standard business practice ("all our suppliers sign a quality agreement") rather than an adversarial negotiation, which encourages compliance-oriented thinking from the supplier.

Common pushback from suppliers includes: resistance to audit rights (compromise by limiting audits to once per year with 30 days notice, but retain the right to cause-based audits with shorter notice), resistance to consequential damage liability (compromise by capping at insurance coverage as described above), resistance to 90-day change notification (compromise at 60 days but do not go below 30 days), and resistance to market-specific regulatory compliance warranties (compromise by identifying the specific regulations applicable to their supplied component rather than the entire end product). Each compromise should be documented in the negotiation record and the final SQA should reflect agreed positions.

Customize the SQA template for each market you serve. The US version should reference FDA 21 CFR regulations, CPSC standards (if applicable), and FTC claim substantiation requirements. The Australia version should reference TGA GMP requirements, FSANZ food standards, ACCC mandatory safety standards, and AICIS chemical notification requirements. The Japan version should reference MHLW Food Sanitation Act standards, Japanese Pharmacopoeia test methods, and JHFA GMP certification expectations. A single generic SQA that does not reference specific market regulations will not provide adequate protection.

Review and update the SQA annually or whenever there are significant changes in: the applicable regulations in your target markets, the supplier's manufacturing processes or facilities, the product specifications or formulation, or the commercial relationship terms (pricing, volume commitments, payment terms). Annual SQA reviews should coincide with annual supplier performance reviews, where you evaluate the supplier's quality performance (defect rates, COA accuracy, audit findings, change notification compliance) against SQA requirements and identify improvement opportunities.